HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors
Key Highlights
- ➤Noémie Heuland joins HealthEquity’s (HQY) board, effective Sept. 24, 2026
- ➤Heuland will serve on HealthEquity’s Audit and Risk Committee
- ➤Heuland will serve on HealthEquity’s Cybersecurity and Technology Committee
- ➤HealthEquity’s board expands to 11 directors, nine independent
- ➤HealthEquity administers HSAs and benefits for nearly 18 million accounts
Expert Statements
Robert Selander, Chairman of the Board of HealthEquity
“Noémie has built her career at the intersection of finance and technology, with deep experience leading through periods of growth and change. Her financial and strategic perspective will be valuable as we continue to scale HealthEquity, invest for the future and navigate the opportunities that come with our next phase of growth.”
Noémie Heuland, Chief Financial Officer of Moody’s Corporation and HealthEquity director
“HealthEquity has built a strong business grounded in an important mission: helping people better manage and pay for healthcare. I look forward to contributing my experience as the Company continues to grow, innovate, and create value for its members, clients and shareholders.”
DRAPER, Utah, Sept. 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that Noémie Heuland, Chief Financial Officer of Moody’s Corporation (NYSE: MCO), has been elected to its board of directors (the “Board”) effective Sept. 24, 2026. Heuland will also serve on the Audit and Risk Committee and Cybersecurity and Technology Committee of the Board. Her appointment expands the Board to 11 directors, nine of whom are independent.
“Noémie has built her career at the intersection of finance and technology, with deep experience leading through periods of growth and change,” said Robert Selander, Chairman of the Board. “Her financial and strategic perspective will be valuable as we continue to scale HealthEquity, invest for the future and navigate the opportunities that come with our next phase of growth.”
Get started
Create a free account to read the full story.